Three cases of severe hepatic impairment caused by erlotinib

Por Huang, Yi-Sheng, An, She-Juan, Chen, Zhi-Hong, Wu, Yi-Long
Publicado em 2009

Effects of sericin on the testicular growth hormone/insulin-like growth factor-1 axis in a rat model of type 2 diabetes

Por Song, Cheng-Jun, Yang, Zhen-Jun, Tang, Qi-Feng, Chen, Zhi-Hong
Publicado no Int J Clin Exp Med (2015)

Bioluminescence Imaging of DNA Synthetic Phase of Cell Cycle in Living Animals

Por Chen, Zhi-Hong, Zhao, Rui-Jun, Li, Rong-Hui, Guo, Cui-Ping, Zhang, Guo-Jun
Publicado em 2013

Discs-Large and Strabismus are functionally linked to plasma membrane formation

Por Lee, Ok-Kyung, Frese, Kristopher K., James, Jennifer S., Chadda, Darshana, Chen, Zhi-Hong, Javier, Ronald T., Cho, Kyung-Ok
Publicado em 2003

The -271 G>A polymorphism of kinase insert domain-containing receptor gene regulates its transcription level in patients with non-small cell lung cancer

Por An, She-Juan, Chen, Zhi-Hong, Lin, Qiu-Xiong, Su, Jian, Chen, Hua-Jun, Lin, Jia-Ying, Wu, Yi-Long
Publicado em 2009

Diversity in early crustal evolution: 4100 Ma zircons in the Cathaysia Block of southern China

Por Xing, Guang-Fu, Wang, Xiao-Lei, Wan, Yusheng, Chen, Zhi-Hong, Jiang, Yang, Kitajima, Kouki, Ushikubo, Takayuki, Gopon, Phillip
Publicado em 2014

Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib

Por Cheng, Hua, An, She-Juan, Dong, Song, Zhang, Yi-Fang, Zhang, Xu-Chao, Chen, Zhi-Hong, Jian-Su, Wu, Yi-Long
Publicado em 2011

Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines

Por Bai, Xiao-Yan, Zhang, Xu-Chao, Yang, Su-Qing, An, She-Juan, Chen, Zhi-Hong, Su, Jian, Xie, Zhi, Gou, Lan-Ying, Wu, Yi-Long
Publicado no PLoS One (2016)

RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy

Por Dong, Song, Guo, Ai-Lin, Chen, Zhi-Hong, Wang, Zhen, Zhang, Xu-Chao, Huang, Ying, Xie, Zhi, Yan, Hong-Hong, Cheng, Hua, Wu, Yi-Long
Publicado em 2010

Targeting mTOR to Overcome Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer Cells

Por Fei, Shi-Jiang, Zhang, Xu-Chao, Dong, Song, Cheng, Hua, Zhang, Yi-Fang, Huang, Ling, Zhou, Hai-Yu, Xie, Zhi, Chen, Zhi-Hong, Wu, Yi-Long
Publicado em 2013

Plasma dynamic monitoring of soluble c-Met level for EGFR-TKI treatment in advanced non-small cell lung cancer

Por Gao, Hong-Fei, Yang, Jin-Ji, Chen, Zhi-Hong, Zhang, Xu-Chao, Yan, Hong-Hong, Guo, Wei-Bang, Zhou, Qing, Gou, Lou-Ying, Dong, Zhong-Yi, Wu, Yi-Long
Publicado no Oncotarget (2016)

Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assay

Por Su, Jian, Zhang, Xu-Chao, An, She-Juan, Zhong, Wen-Zhao, Huang, Ying, Chen, Shi-Liang, Yan, Hong-Hong, Chen, Zhi-Hong, Guo, Wei-Bang, Huang, Xiao-Sui, Wu, Yi-Long
Publicado em 2014

Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer

Por AN, SHE-JUAN, LIN, QIU-XIONG, CHEN, ZHI-HONG, SU, JIAN, CHENG, HUA, XIE, ZHI, ZHANG, XU-CHAO, ZHOU, HAI-YU, HUANG, YING, CHEN, SHI-LIANG, GUO, WEI-BANG, WU, YI-LONG
Publicado em 2012

BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification

Por Jiang, Ben-yuan, Zhang, Xu-chao, Su, Jian, Meng, Wei, Yang, Xue-ning, Yang, Jin-ji, Zhou, Qing, Chen, Zhi-yong, Chen, Zhi-hong, Xie, Zhi, Chen, Shi-liang, Wu, Yi-long
Publicado em 2013

Upregulation of C-X-C chemokine receptor type 1 expression is associated with late-stage gastric adenocarcinoma

Por WANG, JUN PU, HU, WAN MING, WANG, KUAN SONG, LUO, BAI HUA, WU, CHANG, CHEN, ZHI HONG, LUO, GENG QIU, LIU, YU WU, LIU, QIN LAI, YU, JUN, LI, JING HE, WEN, JI FANG
Publicado em 2012

Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial

Por Zhou, Qing, Yang, Jin-Ji, Chen, Zhi-Hong, Zhang, Xu-Chao, Yan, Hong-Hong, Xu, Chong-Rui, Su, Jian, Chen, Hua-Jun, Tu, Hai-Yan, Zhong, Wen-Zhao, Yang, Xue-Ning, Wu, Yi-Long
Publicado no J Hematol Oncol (2016)

Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status

Por An, She-Juan, Chen, Zhi-Hong, Su, Jian, Zhang, Xu-Chao, Zhong, Wen-Zhao, Yang, Jin-Ji, Zhou, Qing, Yang, Xue-Ning, Huang, Ling, Guan, Ji-Lin, Nie, Qiang, Yan, Hong-Hong, Mok, Tony S., Wu, Yi-Long
Publicado em 2012

EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas

Por Chen, Zhi-Yong, Zhong, Wen-Zhao, Zhang, Xu-Chao, Su, Jian, Yang, Xue-Ning, Chen, Zhi-Hong, Yang, Jin-Ji, Zhou, Qing, Yan, Hong-Hong, An, She-Juan, Chen, Hua-Jun, Jiang, Ben-Yuan, Mok, Tony S., Wu, Yi-Long
Publicado em 2012

Development and characterization of monoclonal antibody against human IL-37b

Por Gao, Yu-Chi, Jia, Yan, Xiao, De-Qian, Wang, Xin, Dai, You-Chao, Yu, Shi-Yan, Chen, Chen, Zhuang, Ze-Gang, Fu, Xiao-Xia, Zhang, Jun-Ai, Zheng, Bi-Ying, Chen, Zhi-Hong, Zhong, Ji-Xin, Chen, Zhang-Quan, Xu, Jun-Fa
Publicado no Cytotechnology (2017)

Expression of C-X-C chemokine receptor types 1/2 in patients with gastric carcinoma: Clinicopathological correlations and significance

Por WANG, JUN PU, HU, WAN MING, WANG, KUAN SONG, YU, JUN, LUO, BAI HUA, WU, CHANG, CHEN, ZHI HONG, LUO, GENG QIU, LIU, YU WU, LIU, QIN LAI, XIAO, YAN, ZHOU, HAI YAN, YANG, XIAO JING, JIANG, HAI YING, LI, JING HE, WEN, JI FANG
Publicado em 2013